Process View
Any process that activates or increases the frequency, rate or extent of lymphocyte migration.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of lymphocyte migration"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
DPP4 | dipeptidyl-peptidase 4 | 0.995 | ||
CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.991 | Human | |
CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.990 | Human | |
CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.979 | Human | |
CCR5 | chemokine (C-C motif) receptor 5 | 0.977 | ||
CCL4 | chemokine (C-C motif) ligand 4 | 0.971 | ||
IL8 | interleukin 8 | 0.951 | Human | |
CCL8 | chemokine (C-C motif) ligand 8 | 0.892 | Human | |
CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.875 | Human | |
ABI2 | abl-interactor 2 | 0.874 | ||
CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.748 | ||
CCL13 | chemokine (C-C motif) ligand 13 | 0.624 | Human | |
SNX9 | sorting nexin 9 | 0.590 | ||
NLRC4 | NLR family, CARD domain containing 4 | 0.576 | ||
CCL20 | chemokine (C-C motif) ligand 20 | 0.550 | ||
MAD2L2 | MAD2 mitotic arrest deficient-like 2 (yeast) | 0.533 | ||
IL6 | interleukin 6 (interferon, beta 2) | 0.523 | ||
CCL2 | chemokine (C-C motif) ligand 2 | 0.519 | Human | |
IL1B | interleukin 1, beta | 0.498 | ||
CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.496 | Human | |
TRAF1 | TNF receptor-associated factor 1 | 0.463 | ||
CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.386 | Human | |
CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.316 | Human | |
TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.281 | ||
CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.250 | Human | |
CCL5 | chemokine (C-C motif) ligand 5 | 0.244 | ||
MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.226 | ||
CCL19 | chemokine (C-C motif) ligand 19 | 0.202 | Human | |
CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.171 | ||
IDE | insulin-degrading enzyme | 0.158 | ||
CCL11 | chemokine (C-C motif) ligand 11 | 0.152 | Human | |
CCL7 | chemokine (C-C motif) ligand 7 | 0.146 | ||
TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.145 | ||
CCR1 | chemokine (C-C motif) receptor 1 | 0.136 | ||
TRAM1 | translocation associated membrane protein 1 | 0.122 | ||
CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.118 | ||
VCAM1 | vascular cell adhesion molecule 1 | 0.112 | ||
CCR7 | chemokine (C-C motif) receptor 7 | 0.106 | ||
DNM1 | dynamin 1 | 0.092 | ||
UBD | ubiquitin D | 0.090 | ||
BIRC3 | baculoviral IAP repeat containing 3 | 0.081 | ||
SH3D19 | SH3 domain containing 19 | 0.079 | ||
CCR4 | chemokine (C-C motif) receptor 4 | 0.079 | ||
FPR3 | formyl peptide receptor 3 | 0.077 | ||
SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.061 | ||
MEFV | Mediterranean fever | 0.059 | ||
PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.057 | ||
IFNG | interferon, gamma | 0.053 | ||
SELE | selectin E | 0.053 | ||
CFLAR | CASP8 and FADD-like apoptosis regulator | 0.053 | ||
CCL22 | chemokine (C-C motif) ligand 22 | 0.052 | Human | |
TRADD | TNFRSF1A-associated via death domain | 0.052 | ||
FASLG | Fas ligand (TNF superfamily, member 6) | 0.049 | ||
TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.045 | ||
PTPRA | protein tyrosine phosphatase, receptor type, A | 0.044 | ||
CPD | carboxypeptidase D | 0.044 | ||
SNX33 | sorting nexin 33 | 0.042 | ||
TNF | tumor necrosis factor | 0.042 | ||
PI3 | peptidase inhibitor 3, skin-derived | 0.039 | ||
TRAF2 | TNF receptor-associated factor 2 | 0.038 | ||
CCL3 | chemokine (C-C motif) ligand 3 | 0.037 | ||
NLRP3 | NLR family, pyrin domain containing 3 | 0.036 | ||
IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.033 | ||
MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.032 | ||
TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.031 | ||
CH25H | cholesterol 25-hydroxylase | 0.030 | ||
MATK | megakaryocyte-associated tyrosine kinase | 0.030 | ||
IL32 | interleukin 32 | 0.030 | ||
ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.029 | ||
SPRR2A | small proline-rich protein 2A | 0.028 | ||
CXCR3 | chemokine (C-X-C motif) receptor 3 | 0.028 | ||
CD83 | CD83 molecule | 0.026 | ||
ICAM1 | intercellular adhesion molecule 1 | 0.025 | ||
SLAMF8 | SLAM family member 8 | 0.025 | ||
PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 0.024 | ||
RGS1 | regulator of G-protein signaling 1 | 0.024 | ||
TM9SF2 | transmembrane 9 superfamily member 2 | 0.024 | ||
PDCD6IP | programmed cell death 6 interacting protein | 0.024 | ||
STC2 | stanniocalcin 2 | 0.022 | ||
ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.022 | ||
TNFSF14 | tumor necrosis factor (ligand) superfamily, member 14 | 0.022 | ||
LAMP3 | lysosomal-associated membrane protein 3 | 0.021 | ||
MMP3 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) | 0.020 | ||
AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.019 | ||
PPBP | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | 0.019 | ||
SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.019 | ||
IDO1 | indoleamine 2,3-dioxygenase 1 | 0.019 | ||
IL7R | interleukin 7 receptor | 0.018 | ||
S100A12 | S100 calcium binding protein A12 | 0.018 | ||
BCL2A1 | BCL2-related protein A1 | 0.018 | ||
NPTN | neuroplastin | 0.017 | ||
PIP4K2B | phosphatidylinositol-5-phosphate 4-kinase, type II, beta | 0.017 | ||
ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.017 | ||
ADAMDEC1 | ADAM-like, decysin 1 | 0.017 | Human | |
INHBA | inhibin, beta A | 0.017 | ||
SH3PXD2A | SH3 and PX domains 2A | 0.017 | ||
MMP10 | matrix metallopeptidase 10 (stromelysin 2) | 0.015 | ||
PACSIN3 | protein kinase C and casein kinase substrate in neurons 3 | 0.015 | ||
SOD2 | superoxide dismutase 2, mitochondrial | 0.015 | ||
SLCO2B1 | solute carrier organic anion transporter family, member 2B1 | 0.014 | ||
IL1A | interleukin 1, alpha | 0.014 | ||
BCAR1 | breast cancer anti-estrogen resistance 1 | 0.014 | ||
TLR2 | toll-like receptor 2 | 0.014 | ||
PF4V1 | platelet factor 4 variant 1 | 0.014 | Human | |
HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.013 | ||
C2 | complement component 2 | 0.013 | ||
CD163 | CD163 molecule | 0.013 | ||
IL10 | interleukin 10 | 0.013 | ||
APOC1 | apolipoprotein C-I | 0.012 | ||
CD86 | CD86 molecule | 0.012 | ||
IL1R2 | interleukin 1 receptor, type II | 0.012 | ||
LRP6 | low density lipoprotein receptor-related protein 6 | 0.012 | ||
CD80 | CD80 molecule | 0.012 | ||
DPT | dermatopontin | 0.011 | ||
TMEM30A | transmembrane protein 30A | 0.011 | ||
CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.011 | ||
ANKRD13D | ankyrin repeat domain 13 family, member D | 0.011 | ||
IL1RN | interleukin 1 receptor antagonist | 0.011 | ||
SH3RF3 | SH3 domain containing ring finger 3 | 0.011 | ||
MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.011 | ||
PITPNM1 | phosphatidylinositol transfer protein, membrane-associated 1 | 0.010 | ||
CSF2 | colony stimulating factor 2 (granulocyte-macrophage) | 0.010 | ||
DARC | Duffy blood group, chemokine receptor | 0.010 | ||
IL18R1 | interleukin 18 receptor 1 | 0.010 | ||
ZBTB48 | zinc finger and BTB domain containing 48 | 0.010 | ||
PF4 | platelet factor 4 | 0.010 | Human | |
APOL1 | apolipoprotein L, 1 | 0.010 | ||
IL2RB | interleukin 2 receptor, beta | 0.010 |